## Why "Presence of infiltrating glands, cords, and sheets of malignant epithelial cells with desmoplastic stromal reaction" is right Invasive ductal carcinoma, no special type (IDC-NST), marked as **A**, is defined by malignant epithelial cells arranged in glands, cords, sheets, or single cells infiltrating into the stroma with a prominent desmoplastic (myofibroblastic) stromal response. This desmoplasia is responsible for the firm, gritty texture and stellate mammographic appearance. IDC-NST is the most common form of invasive breast cancer, accounting for 75–80% of cases. The combination of variable architectural patterns (glands, cords, sheets) and the characteristic desmoplastic stromal reaction is the hallmark that distinguishes it from special-type carcinomas. (Robbins 10e, Breast; ASCO/CAP HER2 Testing 2023) ## Why each distractor is wrong - **Single-file infiltration of tumor cells with loss of E-cadherin expression**: This describes invasive lobular carcinoma (ILC), marked as **B**, not IDC-NST. ILC has a distinctive single-file pattern and E-cadherin loss, which is a different histologic subtype with different prognosis and clinical behavior. - **Well-formed tubular structures with excellent prognosis and low nuclear grade**: This describes tubular carcinoma, a special-type subtype of invasive breast cancer with an excellent prognosis. Tubular carcinoma is not the same as IDC-NST; it is a distinct special-type variant with better outcomes. - **Extracellular mucin lakes surrounding nests of tumor cells with predominantly elderly presentation**: This describes mucinous (colloid) carcinoma, another special-type variant that occurs predominantly in elderly patients. It is not the defining feature of IDC-NST. **High-Yield:** IDC-NST is the "default" invasive breast cancer diagnosis—it is defined by variable architectural patterns (glands, cords, sheets) and desmoplasia, and accounts for ~75–80% of invasive breast cancers. All other subtypes are "special types" with distinct histologic and prognostic features. [cite: Robbins 10e — Breast; ASCO/CAP HER2 Testing 2023]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.